Henry Schein Focus on Saleable Returns Verification

This document is a case study discussing Henry Schein's approach to the FDA's enforcement discretion regarding the Drug Supply Chain Security Act (DSCSA) saleable returns verification requirement. It outlines the company's commitment to meeting the original November 2019 deadline for implementing verification solutions despite the FDA's announcement that enforcement would not occur until November 2020. The case study details the operational challenges Henry Schein faces in verifying returned products and the importance of maintaining customer satisfaction. It also emphasizes the need for suppliers to provide Electronic Product Code Information Services (EPCIS) data and verification router service (VRS) capabilities to streamline the returns process. The document highlights the critical role of accurate master data in ensuring system interoperability and effective verification. Additionally, it discusses the urgency for manufacturers to collaborate with distributors to meet verification requests promptly and the complexities involved in establishing efficient data exchange systems. The case study concludes with Henry Schein's reliance on TraceLink for compliance and operational efficiency.